Found 22 matching trials
Intensified Chemotherapy in CRC After Resection of Liver Metastases PHASE2 Randomized, open label, multicentre phase II trial followed by phase III co...
Show More Location
CRLC Val d'Aurelle
Learn More & Join Trial
Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer PHASE4 In this study, the investigators assessed the effect of Cetuximab in combin...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer PHASE3 PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Show More Location
Providence Cancer Center at Providence Hospital
Learn More & Join Trial
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial PHASE3 This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets PHASE2 The purpose of this study is to determine the proportion of patients alive ...
Show More Location
Hospital Universitario de Fuenlabrada
Treatments Being Tested
gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI. Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRI Learn More & Join Trial
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers PHASE1 The purpose of this study is to determine the putative recommended phase 2 ...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer PHASE2 Immune chekpoints (ICI) are evaluated in many digestive cancers. Certain ty...
Show More Location
Ch - Centre Hospitalier D'Abbeville
Learn More & Join Trial
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer PHASE3 The goal of this Phase 3 clinical trial is to evaluate whether continuing c...
Show More Location
A.O.U. Ospedali Riuniti
Learn More & Join Trial
Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer PHASE1 At this moment, FOLFIRINOX is the best treatment for selected patients (pts...
Show More Location
Ospedale Sacro cuore di Gesù - FATEBENEFRATELLI
Learn More & Join Trial
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum PHASE3 This is a randomized phase II study trial that has served as a screening tr...
Show More Location
Northeast Alabama Regional Medical Center
Learn More & Join Trial